Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders : KALIGO+
Recruiting
N/A
Interventional Study
Writing Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 6 – 11
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 15 (estimated)
- Sponsor
- Fondation Ildys · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Writing is a fundamental skill, crucial to a child's success at school and the development of independence. Around 30% of children present difficulties in learning to write, and for some of them (10%), these difficulties persist for a long time. Adapted learning can improve their handwriting. Initial studies into the use of new technologies (tablets, virtual reality headsets) have shown that they …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children with writing difficulties (who may or may not be receiving care in this area)
* Age: 6 - 11 years
* Score \> 1 standard deviation on the BHK deterioration score
Exclusion Criteria:
* Contraindication to the use of the tablet or virtual reality
* Moderate, severe or …
Contacts